Patient attendance at molecular tumor board: A new means of shared decision making?

Precision Oncology Decision Support: Current Approaches and Strategies for the Future

(2018) Katherine C. Kurnit et al.   CLINICAL CANCER RESEARCH

Patient understanding of, satisfaction with, and perceived utility of whole-genome sequencing: findings from the MedSeq Project

(2018) J Scott Roberts et al.   GENETICS IN MEDICINE

2017 FDA drug approvals

(2018) Asher Mullard   NATURE REVIEWS DRUG DISCOVERY

Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs

(2018) Derrick S. Haslem et al.   Oncotarget

From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

(2018) Júlia Perera-Bel et al.   Genome Medicine

Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience

(2017) Todd C. Knepper et al.   ONCOLOGIST

Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials

(2015) Maria Schwaederle et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

(2015) Christophe Le Tourneau et al.   LANCET ONCOLOGY

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center

(2015) L. J. Tafe et al.   ONCOLOGIST

Impact of tumor sequencing on the use of anticancer drugs

(2014) François Thomas et al.   CURRENT OPINION IN ONCOLOGY

Molecular Tumor Board: The University of California San Diego Moores Cancer Center Experience

(2014) M. Schwaederle et al.   ONCOLOGIST

Exploring cancer treatment decision-making by patients: a descriptive study

(2010) D. Stacey et al.   Current Oncology